# huSA: a comprehensive database for multi-dimensional resolution of bulk, single cell and spatial transcription profiles in skin diseases

**Authors:** Meiling Zheng, Bao Qian, Zhi Hu, Xingyu Wei, Ke Sun, Wenjuan Jiang, Changxing Gao, Ming Zhao

PMC · DOI: 10.1093/database/baag009 · Database: The Journal of Biological Databases and Curation · 2026-02-20

## TL;DR

huSA is a new database that combines and analyzes skin disease data from multiple sources to help researchers better understand skin conditions at the molecular level.

## Contribution

The novel contribution is the creation of huSA, an integrative database combining bulk, single-cell, and spatial transcriptomic data across 17 skin diseases.

## Key findings

- huSA integrates 1,434 scRNA-seq, 63 spatial transcriptomics, and 1,502 bulk RNA-seq samples from 17 skin diseases.
- The database provides standardized analyses including cell-type annotations, gene expression, and cell-cell interactions.
- Demonstration analyses show high reliability and biological relevance of results from single or aggregated datasets.

## Abstract

Skin diseases are among the most prevalent conditions worldwide, posing significant threats to human health by causing physical discomfort, psychological distress, and reduced quality of life. With the rapid advancement of high-throughput technologies, a substantial number of transcriptomic datasets, including single-cell RNA sequencing (scRNA-seq), spatial transcriptomics, and bulk RNA-seq, have been generated in the field of dermatology over the past decade. However, the lack of effective integration and standardized analysis pipelines limits the full utilization of these valuable resources in skin disease research.

To address this gap, we aimed to construct a comprehensive, integrative, and user-friendly atlas that enables systematic exploration of skin transcriptomic data across multiple diseases and modalities.

We developed the Human Skin Atlas (huSA) (‘https://humanskinatlas.com/index.html’), a publicly accessible database that incorporates data from 17 skin diseases and 63 independent datasets, including 1 434 scRNA-seq, 63 spatial transcriptomics, and 1 502 bulk RNA-seq samples. The database provides standardized cell-type annotations, differential gene expression analysis, cell-cell interaction mapping, pathway and metabolic module enrichment, transcription factor regulatory inference, and differentiation state assessment for scRNA-seq data. Data from identical skin diseases were further integrated to enhance biological signal detection. For visualization, we embedded the ‘cell × gene’ and ‘Cirrocumulus’ platforms, offering interactive and customizable gene expression visualizations at both single-cell and spatial levels with user-defined parameters.

The huSA enables both individual dataset analysis and cross-dataset integration, providing robust, consistent, and scalable insights into skin disease biology. Demonstration analyses confirmed that results derived from either single datasets or aggregated multi-dataset integrations exhibited high reliability and biological relevance. The platform successfully supports diverse research needs, including cell-type-specific expression profiling, regulatory network construction, and spatial transcriptomic exploration.

The Human Skin Atlas (huSA) represents a state-of-the-art integrative resource for the skin research community. By offering multiscale analyses and interactive visualization tools, the huSA accelerates the discovery of molecular mechanisms underlying skin diseases and facilitates translational research efforts aimed at improving skin health.

## Full-text entities

- **Genes:** EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit) [NCBI Gene 2146] {aka ENX-1, ENX1, EZH2b, KMT6, KMT6A, WVS}, CREB3L1 (cAMP responsive element binding protein 3 like 1) [NCBI Gene 90993] {aka C16DELp11.2, DEL16p11.2, OASIS, OI16}, NEGR1 (neuronal growth regulator 1) [NCBI Gene 257194] {aka DMML2433, IGLON4, KILON, Ntra}, ITGA1 (integrin subunit alpha 1) [NCBI Gene 3672] {aka CD49a, VLA1}, CEBPB (CCAAT enhancer binding protein beta) [NCBI Gene 1051] {aka C/EBP-beta, IL6DBP, NF-IL6, TCF5}, COL1A2 (collagen type I alpha 2 chain) [NCBI Gene 1278] {aka EDSARTH2, EDSCV, OI4}, ETS1 (ETS proto-oncogene 1, transcription factor) [NCBI Gene 2113] {aka ETS-1, EWSR2, c-ets-1, p54}, CCL19 (C-C motif chemokine ligand 19) [NCBI Gene 6363] {aka CKb11, ELC, MIP-3b, MIP3B, SCYA19}, CCR7 (C-C motif chemokine receptor 7) [NCBI Gene 1236] {aka BLR2, CC-CKR-7, CCR-7, CD197, CDw197, CMKBR7}, TNFRSF12A (TNF receptor superfamily member 12A) [NCBI Gene 51330] {aka CD266, FN14, TWEAKR}, CCN5 (cellular communication network factor 5) [NCBI Gene 8839] {aka CT58, CTGF-L, WISP2}, COL18A1 (collagen type XVIII alpha 1 chain) [NCBI Gene 80781] {aka GLCC, KNO, KNO1, KS}, HTRA1 (HtrA serine peptidase 1) [NCBI Gene 5654] {aka ARMD7, CADASIL2, CARASIL, CARASIL2, HtrA, L56}, CXCL14 (C-X-C motif chemokine ligand 14) [NCBI Gene 9547] {aka BMAC, BRAK, KEC, KS1, MIP-2g, MIP2G}, CTSS (cathepsin S) [NCBI Gene 1520], PI16 (peptidase inhibitor 16) [NCBI Gene 221476] {aka CD364, CRISP9, MSMBBP, PSPBP}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, SPHK1 (sphingosine kinase 1) [NCBI Gene 8877] {aka SPHK}, LAMP3 (lysosome associated membrane protein 3) [NCBI Gene 27074] {aka CD208, DC LAMP, DC-LAMP, DCLAMP, LAMP, LAMP-3}, MCAM (melanoma cell adhesion molecule) [NCBI Gene 4162] {aka CD146, HEMCAM, METCAM, MUC18, MelCAM}, IL36G (interleukin 36 gamma) [NCBI Gene 56300] {aka IL-1F9, IL-1H1, IL-1RP2, IL1E, IL1F9, IL1H1}, CPE (carboxypeptidase E) [NCBI Gene 1363] {aka BDVS, CPH, IDDHH}, CXCR4 (C-X-C motif chemokine receptor 4) [NCBI Gene 7852] {aka CD184, D2S201E, FB22, HM89, HSY3RR, LCR1}, WNT5A (Wnt family member 5A) [NCBI Gene 7474] {aka hWNT5A}, NGFR (nerve growth factor receptor) [NCBI Gene 4804] {aka CD271, Gp80-LNGFR, TNFRSF16, p75(NTR), p75NTR}, ROBO1 (roundabout guidance receptor 1) [NCBI Gene 6091] {aka CPHD8, DUTT1, NORS, NYS8, SAX3}, CXCL12 (C-X-C motif chemokine ligand 12) [NCBI Gene 6387] {aka IRH, PBSF, SCYB12, SDF1, TLSF, TPAR1}, SLIT2 (slit guidance ligand 2) [NCBI Gene 9353] {aka SLIL3, Slit-2}, TGFB3 (transforming growth factor beta 3) [NCBI Gene 7043] {aka ARVD, ARVD1, LDS5, RNHF, TGF-beta3}, EFEMP1 (EGF-like fibulin extracellular matrix protein 1) [NCBI Gene 2202] {aka ARCL1D, DHRD, DRAD, FBLN3, FBNL, FIBL-3}, APCDD1 (APC down-regulated 1) [NCBI Gene 147495] {aka B7323, DRAPC1, FP7019, HHS, HTS, HYPT1}, NREP (neuronal regeneration related protein) [NCBI Gene 9315] {aka C5orf13, D4S114, P311, PRO1873, PTZ17, SEZ17}, COL11A1 (collagen type XI alpha 1 chain) [NCBI Gene 1301] {aka CO11A1, COLL6, DFNA37, STL2}, COL3A1 (collagen type III alpha 1 chain) [NCBI Gene 1281] {aka EDS4A, EDSVASC, PMGEDSV}, COL6A5 (collagen type VI alpha 5 chain) [NCBI Gene 256076] {aka COL29A1, VWA4}, COL23A1 (collagen type XXIII alpha 1 chain) [NCBI Gene 91522], TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, TGFB2 (transforming growth factor beta 2) [NCBI Gene 7042] {aka CAEND2, G-TSF, LDS4, TGF-beta2}, TNFSF12 (TNF superfamily member 12) [NCBI Gene 8742] {aka APO3L, DR3LG, TNF12, TNLG4A, TWEAK}, COCH (cochlin) [NCBI Gene 1690] {aka COCH-5B2, COCH5B2, DFNA9, DFNB110}, ITGB1 (integrin subunit beta 1) [NCBI Gene 3688] {aka CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA}, COL1A1 (collagen type I alpha 1 chain) [NCBI Gene 1277] {aka CAFYD, EDSARTH1, EDSC, OI1, OI2, OI3}
- **Diseases:** cutaneous lesions (MESH:D009059), urticaria (MESH:D014581), psoriatic arthritis (MESH:D015535), cutaneous lupus erythematosus (MESH:D008178), psoriasis (MESH:D011565), SLE (MESH:D008180), itch (MESH:D011537), systemic sclerosis (MESH:D012595), Disease (MESH:D004194), inflammation (MESH:D007249), fibrosis (MESH:D005355), metabolic disturbances (MESH:D024821), Skin diseases (MESH:D012871), vitiligo (MESH:D014820), BP (MESH:D010391), asthma (MESH:D001249), neuroinflammation (MESH:D000090862), PN (MESH:D011536), bacterial skin infections (MESH:D001424), contact dermatitis (MESH:D003877), neurogenic inflammation (MESH:D020078), pemphigus (MESH:D010392), immune dysregulation (OMIM:614878), acne (MESH:D000152), AD (MESH:D003876), premature death (MESH:D003643), allergic rhinoconjunctivitis (OMIM:613207)
- **Chemicals:** S1P (MESH:C060506), lipid (MESH:D008055), F2_PI16 (-)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** F7 — Mus musculus (Mouse), Hybridoma (CVCL_C2GU)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12923168/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12923168/full.md

## References

64 references — full list in the complete paper: https://tomesphere.com/paper/PMC12923168/full.md

---
Source: https://tomesphere.com/paper/PMC12923168